Sermorelin

from $47.50

Sermorelin — Growth Hormone & Pituitary Signaling Research

A synthetic growth hormone-releasing hormone (GHRH) analog studied around the biology of pituitary signaling, growth hormone secretion, and neuroendocrine communication, with particular interest in the pathways connecting the hypothalamus, pituitary gland, and GH/IGF-1 axis.

Sermorelin corresponds to the first 29 amino acids of human GHRH, representing the portion responsible for stimulating the GHRH receptor. Research has explored its relationship with pituitary somatotroph activity, pulsatile growth hormone secretion, downstream IGF-1 signaling, and endocrine regulation. Sermorelin was previously FDA-approved as a diagnostic agent and for a pediatric indication, but those products were discontinued; current compounded sermorelin products are not FDA-approved drug products.

Research Focus: GHRH Receptor Signaling • Growth Hormone Physiology • Pituitary Function • GH/IGF-1 Axis • Hormonal Pulsatility • Neuroendocrine Communication • Endocrine Research

A GHRH-based research peptide for those interested in the science of pituitary communication, endogenous growth hormone signaling, hormonal pulsatility, and the endocrine pathways involved in the GH/IGF-1 axis.

Educational Disclaimer

This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.

MG:

Sermorelin — Growth Hormone & Pituitary Signaling Research

A synthetic growth hormone-releasing hormone (GHRH) analog studied around the biology of pituitary signaling, growth hormone secretion, and neuroendocrine communication, with particular interest in the pathways connecting the hypothalamus, pituitary gland, and GH/IGF-1 axis.

Sermorelin corresponds to the first 29 amino acids of human GHRH, representing the portion responsible for stimulating the GHRH receptor. Research has explored its relationship with pituitary somatotroph activity, pulsatile growth hormone secretion, downstream IGF-1 signaling, and endocrine regulation. Sermorelin was previously FDA-approved as a diagnostic agent and for a pediatric indication, but those products were discontinued; current compounded sermorelin products are not FDA-approved drug products.

Research Focus: GHRH Receptor Signaling • Growth Hormone Physiology • Pituitary Function • GH/IGF-1 Axis • Hormonal Pulsatility • Neuroendocrine Communication • Endocrine Research

A GHRH-based research peptide for those interested in the science of pituitary communication, endogenous growth hormone signaling, hormonal pulsatility, and the endocrine pathways involved in the GH/IGF-1 axis.

Educational Disclaimer

This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.

These products are designated solely for research purposes only and is not intended for human consumption. These products are expressly tailored for laboratory inquiries, comprising both in vitro assessments and in vivo animal experiments, to be conducted exclusively by trained professionals. Compliance with all relevant regulations and directives is essential in the handling and deployment of these items. By acquiring these goods, you commit to their utilization strictly in conformity with prevailing regulations and solely for legitimate research purposes. Any unauthorized or improper usage of these products is explicitly prohibited.